PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,472,000 | -38.3% | 228,950 | -32.5% | 0.03% | -39.3% |
| Q1 2015 | $2,387,000 | -26.0% | 339,300 | -18.9% | 0.06% | -36.4% |
| Q4 2014 | $3,224,000 | -5.3% | 418,120 | -8.2% | 0.09% | -17.0% |
| Q3 2014 | $3,403,000 | -27.7% | 455,515 | -6.4% | 0.11% | -29.3% |
| Q2 2014 | $4,709,000 | +19.7% | 486,420 | +2.7% | 0.15% | +19.0% |
| Q1 2014 | $3,935,000 | +10.9% | 473,615 | +12.7% | 0.13% | +13.5% |
| Q4 2013 | $3,547,000 | +13.5% | 420,300 | +7.2% | 0.11% | -6.7% |
| Q3 2013 | $3,126,000 | +114.6% | 392,200 | +107.8% | 0.12% | +98.3% |
| Q2 2013 | $1,457,000 | – | 188,765 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |